| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |